Celltrion Healthcare Co Ltd
KOSDAQ:091990
Celltrion Healthcare Co Ltd
KOSDAQ:091990
Price:
75 900
KRW
-5.6%
Market Closed
Market Cap:
12.5T
KRW
Add
Note
Why Create Notes?
Capture your thoughts
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Estee Lauder Companies Inc
NYSE:EL
|
Consumer products
|
| US |
|
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
| US |
|
Church & Dwight Co Inc
NYSE:CHD
|
Consumer products
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
American Express Co
NYSE:AXP
|
Financial Services
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Target Corp
NYSE:TGT
|
Retail
|
| US |
|
Walt Disney Co
NYSE:DIS
|
Media
|
| US |
|
Mueller Industries Inc
NYSE:MLI
|
Machinery
|
| US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
Technology
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Peter Lynch
Track and Analyze Performance
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Continuous Learning and Adaptation
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
Boost Decision Confidence
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Delete Note
Do you really want to delete this note?
This action cannot be undone.
Alert
Celltrion Healthcare Co Ltd
75900
-4500 (-5.6%)
| 52 Week Range |
69 900
80 400
|
| Price Target |
|
We'll email you a reminder when the closing price reaches KRW.
Choose the stock you wish to monitor with a price alert.
|
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
|
Estee Lauder Companies Inc
NYSE:EL
|
US |
|
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
|
Church & Dwight Co Inc
NYSE:CHD
|
US |
|
|
Pfizer Inc
NYSE:PFE
|
US |
|
|
American Express Co
NYSE:AXP
|
US |
|
|
Nike Inc
NYSE:NKE
|
US |
|
|
Visa Inc
NYSE:V
|
US |
|
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
|
3M Co
NYSE:MMM
|
US |
|
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
|
Coca-Cola Co
NYSE:KO
|
US |
|
|
Target Corp
NYSE:TGT
|
US |
|
|
Walt Disney Co
NYSE:DIS
|
US |
|
|
Mueller Industries Inc
NYSE:MLI
|
US |
|
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
Delete Alert
This alert will be permanently deleted.
Ask me anything about
Celltrion Healthcare Co Ltd
Balance Sheet
Balance Sheet Decomposition
Celltrion Healthcare Co Ltd
Celltrion Healthcare Co Ltd
| Current Assets | 4.5T |
| Cash & Short-Term Investments | 433.4B |
| Receivables | 1.3T |
| Other Current Assets | 2.7T |
| Non-Current Assets | 182.2B |
| Long-Term Investments | 2.8B |
| PP&E | 10.3B |
| Intangibles | 12.3B |
| Other Non-Current Assets | 156.8B |
| Current Liabilities | 2.5T |
| Accounts Payable | 1.7T |
| Accrued Liabilities | 87.5B |
| Short-Term Debt | 292.5B |
| Other Current Liabilities | 447.2B |
| Non-Current Liabilities | 135.8B |
| Long-Term Debt | 4.6B |
| Other Non-Current Liabilities | 131.3B |
Balance Sheet
Celltrion Healthcare Co Ltd
Celltrion Healthcare Co Ltd
Currency: KRW
| Dec-2014 | Dec-2015 | Dec-2016 | Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | ||
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Cash & Cash Equivalents |
4 426
|
36 861
|
95 867
|
251 366
|
240 369
|
296 966
|
231 494
|
254 941
|
458 004
|
|
| Cash |
11
|
5
|
14
|
15
|
14
|
3
|
0
|
0
|
0
|
|
| Cash Equivalents |
4 415
|
36 856
|
95 853
|
251 351
|
240 355
|
296 963
|
231 494
|
254 941
|
458 004
|
|
| Short-Term Investments |
0
|
0
|
0
|
520 000
|
330 708
|
160 621
|
295 695
|
267 130
|
71 088
|
|
| Total Receivables |
40 852
|
62 152
|
364 283
|
420 530
|
448 218
|
549 230
|
847 621
|
977 397
|
1 220 821
|
|
| Accounts Receivables |
40 781
|
62 089
|
364 147
|
418 753
|
446 614
|
518 438
|
750 503
|
925 259
|
1 016 672
|
|
| Other Receivables |
71
|
63
|
136
|
1 777
|
1 604
|
30 792
|
97 118
|
52 138
|
204 150
|
|
| Inventory |
1 186 797
|
1 399 285
|
1 472 120
|
1 574 799
|
1 696 910
|
1 623 600
|
2 034 551
|
2 065 737
|
2 352 890
|
|
| Other Current Assets |
9 731
|
14 164
|
16 883
|
33 526
|
77 172
|
35 854
|
89 501
|
137 536
|
172 864
|
|
| Total Current Assets |
1 241 806
|
1 512 462
|
1 949 153
|
2 800 221
|
2 793 377
|
2 666 271
|
3 498 862
|
3 702 742
|
4 275 666
|
|
| PP&E Net |
345
|
193
|
112
|
315
|
362
|
2 394
|
6 211
|
7 116
|
9 416
|
|
| PP&E Gross |
345
|
193
|
112
|
315
|
362
|
2 394
|
6 211
|
7 116
|
9 416
|
|
| Accumulated Depreciation |
547
|
705
|
842
|
917
|
1 002
|
2 447
|
3 678
|
5 584
|
8 041
|
|
| Intangible Assets |
119
|
221
|
282
|
1 338
|
2 152
|
1 906
|
3 820
|
3 829
|
6 392
|
|
| Goodwill |
734
|
734
|
734
|
734
|
734
|
734
|
734
|
734
|
6 200
|
|
| Note Receivable |
34 137
|
30 740
|
2 142
|
3 973
|
4 152
|
0
|
0
|
6
|
192
|
|
| Long-Term Investments |
0
|
18 882
|
23 100
|
50 285
|
32 658
|
27 072
|
3 983
|
4 384
|
2 256
|
|
| Other Long-Term Assets |
106 558
|
12 293
|
11 918
|
18 079
|
115 135
|
150 529
|
226 088
|
195 883
|
154 476
|
|
| Other Assets |
734
|
734
|
734
|
734
|
734
|
734
|
734
|
734
|
6 200
|
|
| Total Assets |
1 383 699
N/A
|
1 575 526
+14%
|
1 987 441
+26%
|
2 874 946
+45%
|
2 948 569
+3%
|
2 848 905
-3%
|
3 739 698
+31%
|
3 914 694
+5%
|
4 454 599
+14%
|
|
| Liabilities | ||||||||||
| Accounts Payable |
326 027
|
580 201
|
641 305
|
659 243
|
646 329
|
570 678
|
955 355
|
736 087
|
1 441 494
|
|
| Accrued Liabilities |
18 296
|
11 033
|
5 032
|
7 468
|
1 795
|
22 297
|
95 634
|
24 893
|
148 633
|
|
| Short-Term Debt |
10 993
|
9 360
|
22 666
|
11 269
|
16 824
|
114 429
|
197 634
|
398 927
|
358 658
|
|
| Current Portion of Long-Term Debt |
165 922
|
5 789
|
166 109
|
0
|
0
|
1 147
|
2 232
|
2 417
|
3 681
|
|
| Other Current Liabilities |
531 780
|
93 892
|
308 260
|
315 364
|
614 187
|
362 522
|
406 919
|
481 889
|
292 436
|
|
| Total Current Liabilities |
1 053 018
|
700 275
|
1 143 372
|
993 344
|
1 279 135
|
1 071 072
|
1 657 774
|
1 644 213
|
2 244 902
|
|
| Long-Term Debt |
144 604
|
154 563
|
0
|
0
|
0
|
788
|
3 053
|
3 535
|
4 309
|
|
| Deferred Income Tax |
0
|
0
|
0
|
161
|
232
|
4
|
41 492
|
61 431
|
61 442
|
|
| Minority Interest |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Liabilities |
870 748
|
221 010
|
195 416
|
173 967
|
33 723
|
111 147
|
104 449
|
99 748
|
82 154
|
|
| Total Liabilities |
2 068 370
N/A
|
1 075 847
-48%
|
1 338 788
+24%
|
1 167 472
-13%
|
1 313 091
+12%
|
1 183 011
-10%
|
1 806 769
+53%
|
1 808 927
+0%
|
2 392 807
+32%
|
|
| Equity | ||||||||||
| Common Stock |
1 658
|
2 772
|
112 084
|
137 338
|
140 527
|
143 928
|
151 810
|
155 028
|
158 242
|
|
| Retained Earnings |
797 244
|
776 660
|
205 603
|
264 698
|
267 463
|
329 641
|
562 932
|
712 496
|
816 753
|
|
| Additional Paid In Capital |
144 211
|
1 323 556
|
380 642
|
1 365 601
|
1 377 026
|
1 390 657
|
1 408 552
|
1 412 551
|
1 417 272
|
|
| Unrealized Security Profit/Loss |
0
|
0
|
0
|
0
|
0
|
7
|
167
|
11
|
89
|
|
| Treasury Stock |
0
|
0
|
0
|
0
|
96 165
|
114 060
|
116 968
|
128 592
|
219 641
|
|
| Other Equity |
33 296
|
49 990
|
49 677
|
60 164
|
53 371
|
84 279
|
73 229
|
45 726
|
110 924
|
|
| Total Equity |
684 671
N/A
|
499 679
N/A
|
648 653
+30%
|
1 707 473
+163%
|
1 635 478
-4%
|
1 665 894
+2%
|
1 932 930
+16%
|
2 105 768
+9%
|
2 061 791
-2%
|
|
| Total Liabilities & Equity |
1 383 699
N/A
|
1 575 526
+14%
|
1 987 441
+26%
|
2 874 946
+45%
|
2 948 569
+3%
|
2 848 905
-3%
|
3 739 698
+31%
|
3 914 694
+5%
|
4 454 599
+14%
|
|
| Shares Outstanding | ||||||||||
| Common Shares Outstanding |
74
|
124
|
125
|
153
|
152
|
152
|
153
|
159
|
161
|
|
Switch to:
Switch to:
See Also
Discover More
You don't have any saved screeners yet
